Eylea and Salivary gland cancer - from FDA reports


Summary

There is no Salivary gland cancer reported by people who take Eylea yet. This review analyzes which people have Salivary gland cancer with Eylea. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Eylea and have Salivary gland cancer, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 18, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Salivary gland cancer when taking Eylea?

Expand the study to include all drugs with the same ingredients

Salivary gland cancer and drugs with ingredients of aflibercept.

Expand the study to include reports from both FDA and eHealthMe

Salivary gland cancer and Eylea from FDA and eHealthMe reports

Eylea

Eylea has active ingredients of aflibercept. It is often used in macular degeneration. (latest outcomes from Eylea 6,687 users)

Salivary Gland Cancer

Salivary gland cancer has been reported by people with multiple sclerosis, rheumatoid arthritis, osteosarcoma, high blood pressure, multiple myeloma (latest reports from 503 Salivary gland cancer patients).

Browse all side effects of Eylea

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Salivary gland cancer

Salivary gland cancer

Could your condition cause Salivary gland cancer

Salivary gland cancer

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Eylea and have Salivary gland cancer.

User reviews to the study

More reviews >